Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.

Vo DT, Karanam NK, Ding L, Saha D, Yordy JS, Giri U, Heymach JV, Story MD.

Neoplasia. 2019 Sep;21(9):849-862. doi: 10.1016/j.neo.2019.06.004. Epub 2019 Jul 18.

2.

Cellular energetics and mitochondrial uncoupling in canine aging.

Nicholatos JW, Robinette TM, Tata SVP, Yordy JD, Francisco AB, Platov M, Yeh TK, Ilkayeva OR, Huynh FK, Dokukin M, Volkov D, Weinstein MA, Boyko AR, Miller RA, Sokolov I, Hirschey MD, Libert S.

Geroscience. 2019 Apr;41(2):229-242. doi: 10.1007/s11357-019-00062-6. Epub 2019 Apr 1.

3.

Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.

Ding C, Chun SG, Sumer BD, Nedzi LA, Abdulrahman RE, Yordy JS, Lee P, Hrycushko B, Solberg TD, Ahn C, Timmerman RD, Schwartz DL.

Med Dosim. 2017 Summer;42(2):90-96. doi: 10.1016/j.meddos.2017.01.004. Epub 2017 Apr 21.

PMID:
28438431
4.

A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck.

Chun SG, Hughes R, Sumer BD, Myers LL, Truelson JM, Khan SA, Ma TW, Xie Y, Yordy JS, Cooley S, Wu J, Choy H, Nedzi LA.

Cancer Invest. 2017 Jan 2;35(1):23-31. doi: 10.1080/07357907.2016.1213275. Epub 2016 Nov 28.

PMID:
27892728
5.

Kinship, maternal effects, and management: Juvenile mortality and survival in captive African painted dogs, Lycaon pictus.

Yordy J, Mossotti RH.

Zoo Biol. 2016 Sep;35(5):367-377. doi: 10.1002/zoo.21306. Epub 2016 Jun 8.

PMID:
27272949
6.

NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.

Li LS, Reddy S, Lin ZH, Liu S, Park H, Chun SG, Bornmann WG, Thibodeaux J, Yan J, Chakrabarti G, Xie XJ, Sumer BD, Boothman DA, Yordy JS.

Mol Cancer Ther. 2016 Jul;15(7):1757-67. doi: 10.1158/1535-7163.MCT-15-0765. Epub 2016 Apr 12.

7.

Driver Missense Mutation Identification Using Feature Selection and Model Fusion.

Soliman AT, Meng T, Chen SC, Iyengar SS, Iyengar P, Yordy J, Shyu ML.

J Comput Biol. 2015 Dec;22(12):1075-85. doi: 10.1089/cmb.2015.0110. Epub 2015 Sep 24.

PMID:
26402258
8.

Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers.

Chun SG, Park H, Pandita RK, Horikoshi N, Pandita TK, Schwartz DL, Yordy JS.

Am J Cancer Res. 2015 Mar 15;5(4):1337-52. eCollection 2015.

9.

Sublethal red tide toxin exposure in free-ranging manatees (Trichechus manatus) affects the immune system through reduced lymphocyte proliferation responses, inflammation, and oxidative stress.

Walsh CJ, Butawan M, Yordy J, Ball R, Flewelling L, de Wit M, Bonde RK.

Aquat Toxicol. 2015 Apr;161:73-84. doi: 10.1016/j.aquatox.2015.01.019. Epub 2015 Jan 22.

PMID:
25678466
10.

Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.

Neskey DM, Osman AA, Ow TJ, Katsonis P, McDonald T, Hicks SC, Hsu TK, Pickering CR, Ward A, Patel A, Yordy JS, Skinner HD, Giri U, Sano D, Story MD, Beadle BM, El-Naggar AK, Kies MS, William WN, Caulin C, Frederick M, Kimmel M, Myers JN, Lichtarge O.

Cancer Res. 2015 Apr 1;75(7):1527-36. doi: 10.1158/0008-5472.CAN-14-2735. Epub 2015 Jan 29.

11.

Automated landmark-guided deformable image registration.

Kearney V, Chen S, Gu X, Chiu T, Liu H, Jiang L, Wang J, Yordy J, Nedzi L, Mao W.

Phys Med Biol. 2015 Jan 7;60(1):101-16. doi: 10.1088/0031-9155/60/1/101. Epub 2014 Dec 5.

PMID:
25479095
12.

A retrospective analysis of tumor volumetric responses to five-fraction stereotactic radiotherapy for paragangliomas of the head and neck (glomus tumors).

Chun SG, Nedzi LA, Choe KS, Abdulrahman RE, Chen SA, Yordy JS, Timmerman RD, Kutz JW, Isaacson B.

Stereotact Funct Neurosurg. 2014;92(3):153-9. doi: 10.1159/000360864. Epub 2014 May 7.

PMID:
24818638
13.

Commissioning and initial stereotactic ablative radiotherapy experience with Vero.

Solberg TD, Medin PM, Ramirez E, Ding C, Foster RD, Yordy J.

J Appl Clin Med Phys. 2014 Mar 6;15(2):4685. doi: 10.1120/jacmp.v15i2.4685.

14.

Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.

Cao L, Li LS, Spruell C, Xiao L, Chakrabarti G, Bey EA, Reinicke KE, Srougi MC, Moore Z, Dong Y, Vo P, Kabbani W, Yang CR, Wang X, Fattah F, Morales JC, Motea EA, Bornmann WG, Yordy JS, Boothman DA.

Antioxid Redox Signal. 2014 Jul 10;21(2):237-50. doi: 10.1089/ars.2013.5462. Epub 2014 Apr 3.

15.

Wavelet analysis in current cancer genome research: a survey.

Meng T, Soliman AT, Shyu ML, Yang Y, Chen SC, Iyengar SS, Yordy JS, Iyengar P.

IEEE/ACM Trans Comput Biol Bioinform. 2013 Nov-Dec;10(6):1442-59. doi: 10.1109/TCBB.2013.134. Review.

PMID:
24407303
16.

Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice.

Gupta A, Hunt CR, Chakraborty S, Pandita RK, Yordy J, Ramnarain DB, Horikoshi N, Pandita TK.

Radiat Res. 2014 Jan;181(1):1-8. doi: 10.1667/RR13572.1. Epub 2013 Dec 9. Review.

17.

Epigonal conditioned media from bonnethead shark, Sphyrna tiburo, induces apoptosis in a T-cell leukemia cell line, Jurkat E6-1.

Walsh CJ, Luer CA, Yordy JE, Cantu T, Miedema J, Leggett SR, Leigh B, Adams P, Ciesla M, Bennett C, Bodine AB.

Mar Drugs. 2013 Aug 26;11(9):3224-57. doi: 10.3390/md11093224.

18.

Levels of chlorinated, brominated, and perfluorinated contaminants in birds of prey spanning multiple trophic levels.

Yordy JE, Rossman S, Ostrom PH, Reiner JL, Bargnesi K, Hughes S, Elliot JD.

J Wildl Dis. 2013 Apr;49(2):347-54. doi: 10.7589/2012-03-084.

PMID:
23568910
19.

A contour-guided deformable image registration algorithm for adaptive radiotherapy.

Gu X, Dong B, Wang J, Yordy J, Mell L, Jia X, Jiang SB.

Phys Med Biol. 2013 Mar 21;58(6):1889-901. doi: 10.1088/0031-9155/58/6/1889. Epub 2013 Feb 27.

PMID:
23442596
20.

Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?

Chun SG, Choe KS, Iyengar P, Yordy JS, Timmerman RD.

Cancer Biol Ther. 2012 Dec;13(14):1376-83. doi: 10.4161/cbt.22255. Epub 2012 Sep 17.

21.

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

Byers LA, Wang J, Nilsson MB, Fujimoto J, Saintigny P, Yordy J, Giri U, Peyton M, Fan YH, Diao L, Masrorpour F, Shen L, Liu W, Duchemann B, Tumula P, Bhardwaj V, Welsh J, Weber S, Glisson BS, Kalhor N, Wistuba II, Girard L, Lippman SM, Mills GB, Coombes KR, Weinstein JN, Minna JD, Heymach JV.

Cancer Discov. 2012 Sep;2(9):798-811. doi: 10.1158/2159-8290.CD-12-0112. Epub 2012 Sep 6.

22.

TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.

Skinner HD, Sandulache VC, Ow TJ, Meyn RE, Yordy JS, Beadle BM, Fitzgerald AL, Giri U, Ang KK, Myers JN.

Clin Cancer Res. 2012 Jan 1;18(1):290-300. doi: 10.1158/1078-0432.CCR-11-2260. Epub 2011 Nov 16.

23.

Development of the M. D. Anderson Cancer Center gynecologic applicators for the treatment of cervical cancer: historical analysis.

Yordy JS, Almond PR, Delclos L.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1445-53. doi: 10.1016/j.ijrobp.2011.05.029. Epub 2011 Sep 21.

PMID:
21940113
24.

Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms.

Findlay VJ, Turner DP, Yordy JS, McCarragher B, Shriver MR, Szalai G, Watson PM, Larue AC, Moussa O, Watson DK.

Genes Cancer. 2011 Feb;2(2):120-9. doi: 10.1177/1947601911410424.

25.

Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA.

J Clin Oncol. 2011 Aug 1;29(22):3037-43. doi: 10.1200/JCO.2010.33.8038. Epub 2011 Jun 27.

26.

Bottlenose dolphins as indicators of persistent organic pollutants in the western North Atlantic Ocean and northern Gulf of Mexico.

Kucklick J, Schwacke L, Wells R, Hohn A, Guichard A, Yordy J, Hansen L, Zolman E, Wilson R, Litz J, Nowacek D, Rowles T, Pugh R, Balmer B, Sinclair C, Rosel P.

Environ Sci Technol. 2011 May 15;45(10):4270-7. doi: 10.1021/es1042244. Epub 2011 Apr 28.

PMID:
21526819
27.

DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy.

Moeller BJ, Yordy JS, Williams MD, Giri U, Raju U, Molkentine DP, Byers LA, Heymach JV, Story MD, Lee JJ, Sturgis EM, Weber RS, Garden AS, Ang KK, Schwartz DL.

Clin Cancer Res. 2011 Apr 1;17(7):2035-43. doi: 10.1158/1078-0432.CCR-10-2641. Epub 2011 Feb 24.

28.

Blasted cell line names.

Wang J, Byers LA, Yordy JS, Liu W, Shen L, Baggerly KA, Giri U, Myers JN, Ang KK, Story MD, Girard L, Minna JD, Heymach JV, Coombes KR.

Cancer Inform. 2010 Oct 14;9:251-5. doi: 10.4137/CIN.S5613.

29.

Complex contaminant exposure in cetaceans: a comparative E-Screen analysis of bottlenose dolphin blubber and mixtures of four persistent organic pollutants.

Yordy JE, Mollenhauer MA, Wilson RM, Wells RS, Hohn A, Sweeney J, Schwacke LH, Rowles TK, Kucklick JR, Peden-Adams MM.

Environ Toxicol Chem. 2010 Oct;29(10):2143-53. doi: 10.1002/etc.279.

PMID:
20872675
30.

Tissue-specific distribution and whole-body burden estimates of persistent organic pollutants in the bottlenose dolphin (Tursiops truncatus).

Yordy JE, Pabst DA, McLellan WA, Wells RS, Rowles TK, Kucklick JR.

Environ Toxicol Chem. 2010 Jun;29(6):1263-73. doi: 10.1002/etc.152.

PMID:
20821568
31.

Partitioning of persistent organic pollutants between blubber and blood of wild bottlenose dolphins: implications for biomonitoring and health.

Yordy JE, Wells RS, Balmer BC, Schwacke LH, Rowles TK, Kucklick JR.

Environ Sci Technol. 2010 Jun 15;44(12):4789-95. doi: 10.1021/es1004158.

PMID:
20491435
32.

Life history as a source of variation for persistent organic pollutant (POP) patterns in a community of common bottlenose dolphins (Tursiops truncatus) resident to Sarasota Bay, FL.

Yordy JE, Wells RS, Balmer BC, Schwacke LH, Rowles TK, Kucklick JR.

Sci Total Environ. 2010 Apr 1;408(9):2163-72. doi: 10.1016/j.scitotenv.2010.01.032. Epub 2010 Feb 16.

PMID:
20163825
33.

Comparison of five extraction methods for measuring PCBs, PBDEs, organochlorine pesticides, and lipid content in serum.

Keller JM, Swarthout RF, Carlson BK, Yordy J, Guichard A, Schantz MM, Kucklick JR.

Anal Bioanal Chem. 2009 Jan;393(2):747-60. doi: 10.1007/s00216-008-2453-6. Epub 2008 Oct 29.

PMID:
18958450
34.

Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.

Moussa O, Yordy JS, Abol-Enein H, Sinha D, Bissada NK, Halushka PV, Ghoneim MA, Watson DK.

Cancer Res. 2005 Dec 15;65(24):11581-7.

35.

SP100 inhibits ETS1 activity in primary endothelial cells.

Yordy JS, Moussa O, Pei H, Chaussabel D, Li R, Watson DK.

Oncogene. 2005 Jan 27;24(5):916-31.

PMID:
15592518
36.

SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion.

Yordy JS, Li R, Sementchenko VI, Pei H, Muise-Helmericks RC, Watson DK.

Oncogene. 2004 Aug 26;23(39):6654-65.

PMID:
15247905
37.

EAPII interacts with ETS1 and modulates its transcriptional function.

Pei H, Yordy JS, Leng Q, Zhao Q, Watson DK, Li R.

Oncogene. 2003 May 8;22(18):2699-709.

PMID:
12743594
38.

Signal transduction and the Ets family of transcription factors.

Yordy JS, Muise-Helmericks RC.

Oncogene. 2000 Dec 18;19(55):6503-13. Review.

39.

Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: a review of US clinical studies 1987-1990. Hemophilia Study Group.

Watt RM, Bunitsky K, Faulkner EB, Hart CM, Horan J, Ramstack JM, Viola JL, Yordy JR.

Transfus Sci. 1992 Apr;13(2):233-53.

PMID:
10183946
40.

Rates of dissolution and biodegradation of water-insoluble organic compounds.

Thomas JM, Yordy JR, Amador JA, Alexander M.

Appl Environ Microbiol. 1986 Aug;52(2):290-6.

41.

Microbial metabolism of N-nitrosodiethanolamine in lake water and sewage.

Yordy JR, Alexander M.

Appl Environ Microbiol. 1980 Mar;39(3):559-65.

Supplemental Content

Support Center